logo

Daré Bioscience, Inc (DARE)



Trade DARE now with
  Date
  Headline
6/30/2022 8:09:05 AM Daré Bioscience Announces Closing Of Global License Agreement With Organon To Commercialize XACIATO
5/12/2022 6:08:49 AM Daré Bioscience Q1 Loss Per Share $0.10 Vs Loss $0.16 Last Year
8/12/2021 8:14:32 AM Daré Bioscience Q2 Loss Per Share $0.18 Vs Loss $0.21 Last Year
6/28/2021 8:29:57 AM Daré Bioscience Announces Positive Topline Results From Phase 1 Trial Of DARE-HRT1
3/24/2021 8:26:23 AM Daré Bioscience Begins Phase 2b RESPOND Study Of Sildenafil Cream, 3.6% In Women With Female Sexual Arousal Disorder